Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PAX3 and PAX7 Binding Protein 1 (PAXBP1) (Middle Region) Peptide

PAXBP1 Reactivité: Humain Hôte: Synthetic BP
N° du produit ABIN8107703
168,15 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour PAX3 and PAX7 Binding Protein 1 (PAXBP1) (Middle Region) Peptide (ABIN8107703)

Antigène

PAX3 and PAX7 Binding Protein 1 (PAXBP1)

Origine

Humain

Source

  • 7
Synthetic

Application

Blocking Peptide (BP)
  • Protein Region

    Middle Region

    Fonction

    PAXBP1 Peptide - middle region

    Séquence

    KRQMARELGD FTPHDNEPGK GRLVREDEND ASDDEDDDEK RRIVFSVKEK
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    This is a synthetic peptide designed for use in combination with anti- GCFC1 Antibody (ARP83373_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Antigène

    PAX3 and PAX7 Binding Protein 1 (PAXBP1)

    Sujet

    Background Information: This gene encodes a protein that may bind to GC-rich DNA sequences, which suggests its involvement in the regulation of transcription. Alternative splicing of this gene results in multiple transcript variants.

    Alternative Symbols: GCFC, BM020, GCFC1, FSAP105, C21orf66

    Poids moléculaire

    93 kDa

    ID gène

    94104

    NCBI Accession

    NP_037461

    UniProt

    Q9Y5B6
Vous êtes ici:
Chat with us!